Lifestyle adjustment, in combination with symptomatic pharmacologic treatment, allows most patients, particularly those with an inability to stay awake during the day, to live a relatively normal life. New pharmacologic substances show encouraging results in phase 2 and 3 studies to improve the current situation. More dedicated studies in IH, particularly in those who suffer from an increased need for sleep, are needed.
Keywords: Idiopathic hypersomnia; Narcolepsy; Nonpharmacologic treatment; Pharmacologic treatment; Pitolisant; Sodium oxybate; Stimulants.
Copyright © 2022 Elsevier Inc. All rights reserved.